Synthetic Brain Network Model for Epilepsy Susceptibility Assessment

The patent creates a computational copy of brain network dynamics through synthetic data generation. Instead of using expensive video-EEG equipment to observe actual seizures, the system generates synthetic brain activity data that replicates seizure patterns based on routine EEG data, thereby achieving diagnostic accuracy without requiring costly specialized equipment.

The patent replaces the mechanical/video-EEG observation system with a computational modeling system. Rather than physically recording and analyzing video-EEG data during seizures, the system uses computational models to simulate brain network dynamics and predict seizure likelihood from routine EEG data, substituting mechanical observation with computational analysis.

The patent performs preliminary computational analysis on routine EEG data to assess seizure susceptibility before prolonged recording is needed. By generating synthetic data and computing seizure likelihood metrics from standard EEG recordings, the system can identify patients who need further monitoring and predict those at high risk, reducing the need for time-consuming prolonged recordings for all patients.

The patent introduces computational modeling as an intermediary between routine EEG data and diagnostic certainty. Instead of directly requiring prolonged recordings to achieve diagnostic confidence, the system uses computational models as an intermediate step that extracts predictive information from routine data, reducing the need for extended monitoring.

The patent implements a feedback mechanism where computational models continuously assess seizure susceptibility in response to AED treatment. By monitoring changes in synthetic data metrics and seizure likelihood predictions, the system provides objective feedback on treatment efficacy, allowing clinicians to adjust medication based on quantitative response data rather than waiting for trial-and-error progression.

The patent uses parameter changes in computational models to assess treatment response. By tracking changes in synthetic brain activity parameters and seizure susceptibility metrics in response to AED administration, the system quantifies treatment effects, enabling more efficient medication selection compared to conventional methods that rely on observing seizure frequency changes over extended periods.

The patent introduces computational modeling as an intermediary between raw EEG data and clinical interpretation. The system generates synthetic brain activity data and calculates objective seizure susceptibility metrics that serve as a bridge between complex EEG patterns and clinical decision-making, providing quantified assistance that maintains clinical flexibility while improving diagnostic precision.

The patent creates a composite diagnostic approach combining subjective clinical expertise with objective computational metrics. By integrating clinician interpretation with quantitative synthetic data analysis and seizure likelihood predictions, the system forms a composite diagnostic tool that leverages both human flexibility and machine precision.